Industry News
Phosphagenics enters horse supplement tie-up
Phosphagenics (ASX:POH) and Equine Nutrition Australia will collaborate to create equine nutritional supplements using the former's TPM technology. [ + ]
Positive at last: a pure phosphorus cation
A research team led by Prof Dr Ingo Krossing from the Faculty of Chemistry, Pharmacy, and Earth Sciences of the University of Freiburg has now succeeded in creating a positively charged pure phosphorus compound. [ + ]
Automated system to detect infectious diseases for Olympics 2012
The world’s first comprehensive, automated outbreak detection system will monitor over 3000 infections and is ready to run during the 2012 Olympics. [ + ]
Bioxyne's COPD clinical trial disappoints
Shares in Bioxyne (ASX:BSN) sank 82% on Thursday, after the company revealed a trial of HI 164 OV showed clinical benefit only in COPD patients younger than 65. [ + ]
Victorian Government opens ‘Investing in Manufacturing Technology’ Grants
Grants of up to $250,000 are available under the Investing in Manufacturing Technology (IMT) grants scheme to assist businesses to purchase and integrate new technologies into their business. [ + ]
Stable antibody breakthrough solves sticky biotech problem
Researchers at the Garvan Institute have developed a new technique to produce antibodies that are resistant to clinging together into a sticky mess, solving a longstanding technical problem in biotech. [ + ]
Bell Potter downgrades QRxPharma after FDA shock
Bell Potter Securities has reset its optimistic target valuation of QRxPharma from $3.69 to $1.26 after the FDA failed to approve the company’s MoxDuo IR. [ + ]
BioDiem licenses hepatitis vaccine tech from UC
BioDiem (ASX:BDM) has signed its second vaccine technology licensing deal this week, securing exclusive rights to IP with potential applications in hepatitis B and D. [ + ]
QRxPharma shares tumble after FDA knockback for MoxDuo IR
Shares down over 50% after the FDA requests more information on safety and efficacy from QRxPharma on its MoxDuo IR before granting regulatory approval. [ + ]
Free app makes it easier to work with technical gases
As anyone who works with them will tell you, it is impossible to know everything about technical gases off by heart. But now there is no need to: iGASES, the new app from Witt for iPhone, iPad and Android devices, answers your questions, even interactively. [ + ]
Final days for early bird for AusBiotech 2012
Register in the next four days (by 30 June) for the industry event of the year and save $250 with early bird rates. [ + ]
Feature: Raising the bar on IP
From 15 April 2013 patents will be significantly harder to secure in Australia. We look at the implications of the Raising the Bar bill on Australian life science organisations. [ + ]
Chemistry right for award-winning UWS student
A University of Western Sydney student’s high-calibre chemistry experiments, which may lead to better cancer detection, have been recognised by the Royal Australian Chemical Institute. [ + ]
BioDiem closes dengue fever deal
BioDiem (ASX:BDM) and ANU have finalised the terms of the exclusive licensing deal covering a vaccine technology for diseases such as dengue fever. [ + ]
CogState signs licensing deal with Merck Canada
CogState (ASX:CGS) has signed the first of a planned series of licensing deals to have its tests sold to GPs for the detection of neurodegenerative conditions. [ + ]
